Skip to search formSkip to main contentSkip to account menu

3,4-Dihydroxyphenylserine

Known as: 3,4 Dihydroxyphenylserine 
National Institutes of Health

Papers overview

Semantic Scholar uses AI to extract papers important to this topic.
2004
2004
SummaryIntraperitoneal injection of the (+)-erythro isomer of 3,4-dihydroxyphenylserine (DOPS) to rats markedly increased the… 
1990
1990
Summary1.Earlier reports from this and other laboratories have indicated that wide variations exist in estimates of the… 
1987
1987
Abstract: The effects of 3,4‐dihydroxyphenylserine (DOPS), a nonnatural precursor of noradrenaline, on the sleep‐wakefulness… 
1986
1986
Abstract: The effects of diastereomers of 3,4‐dihydroxyphenylserine (DOPS) on the enzyme activity of monoamine oxidase (MAO) in… 
Highly Cited
1983
Highly Cited
1983
The question of the existence of a p‐tyrosine decarboxylase pathway for the formation of p‐tyramine in mammalian tissues remains… 
1976
1976
The enzymic decarboxylation of stereoisomers of DOPS was examined using rat brain and kidney decarboxylase. Optimal assay… 
Highly Cited
1975
Highly Cited
1975
The action of the four stereoisomers of 3,4-dihydroxyphenylserine (DOPS) on the monoamine content of brain and heart was… 
1972
1972
The involvement of brain catecholamines (CA) in the neuroendocrine mechanism(s) that controls the secretion of pituitary… 
1950
1950
THE possibility that noradrenaline carboxylic acid, 3,4-dihydroxyphenylserine, might be a precursor of adrenaline has been…